NIH supported early testing of the artificial retina. Now, scientists are testing whether manufacturing it on the International Space Station results in a viable treatment for people with blinding eye diseases.
Using laboratory-grown roundworms as well as human and mouse eye tissue, University of Maryland School of Medicine (UMSOM) researchers have identified a new potential mechanism for age-related macular degeneration—the leading cause of blindness among older adults.
Michael S. Gilmore, PhD, a renowned microbiologist who has led infectious disease efforts at leading research institutions, has been appointed the first Chief Scientific Officer at Mass Eye and Ear, a member hospital of Mass General Brigham, following an extensive search.
Human brains can do more than simply imagine the presence of nonexistent objects. Our minds can automatically create well-defined representations of objects that are merely implied rather than seen, like the obstacles in a mime’s performance. These findings could aid in the development of artificial intelligence related to vision and navigation by helping understand how humans perceive and navigate their environments.
People who consume alcohol moderately appear less likely to develop cataracts that require surgery. The new research was published as an Article In Press in Ophthalmology, the journal of the American Academy of Ophthalmology.
Early treatment with anti-VEGF injections slowed diabetic retinopathy in a clinical study from the DRCR Retina Network (DRCR.net). However, two years into the four-year study its effect on vision was similar to standard treatment, which usually begins at the onset of late disease.
The discovery of a new gene linked to eye disorders of cataract and small or reduced eye tissue at the University of Delaware has earned a four-year grant to support further work exploring the role of the gene, Elav11 and its partners in eye development.
A recently announced initiative from the American Academy of Ophthalmology to protect children from the vision-threatening consequences of high myopia (nearsightedness) has attracted major financial support from CooperVision.
More patients than previously reported may experience hearing symptoms such as hearing loss or muffled hearing from a new treatment for thyroid eye disease, teprotumumab (Tepezza), according to a small study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
The National Eye Institute (NEI) Data Commons now enables researchers to access data from patients with macular degeneration who participated in the Age-related Eye Disease Study 2 (AREDS2). The database complements newly available stem cell lines created by the New York Stem Cell Foundation Research Institute (NYSCF) from blood cells of AREDS2 study participants.
During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Wednesday.
Glaucoma, the second leading cause of blindness in the world behind cataracts, is often referred to as “the silent thief of sight” because it can so easily go undetected.
Pediatricians can identify vision problems in children. However, there are signs parents themselves can spot.
Delayed checkups and routine screenings due to COVID-19 have been common.
Are contact lenses right for your child? When might be a good time for your child to wear them?
In honor of March’s designation as Workplace Eye Wellness Month, the American Academy of Ophthalmology is sharing tips on how to create a comfortable work environment at home to avoid digital eye strain.
Blue light-blocking glasses, with digital device usage on the rise during the COVID-19 pandemic (particularly among children and adolescents), continue to grow in popularity.
The Glaucoma Foundation (TGF) and Research to Prevent Blindness (RPB) have partnered to launch a new grant aimed at supporting under-represented racial and ethnic minority researchers in the pursuit of glaucoma research. The TGF (sponsored by Patricia Hill) / RPB Fellowships in Glaucoma provide one-year, $10,000 fellowships focused on substantive glaucoma research.
Being able to make blind people see again sounds like the stuff of miracles or even science fiction. And it has always been one of the biggest challenges for scientists.
A meta-analysis finds that vision impairment and blindness are tied to an increased risk of mortality, prompting the need to address global eye health disparities.
During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Wednesday.
Researchers at UC San Diego Health see a possible way to detect heart disease through the eye.
Glaucoma Research Foundation (GRF) today announced a total of $1.7 million in annual research grants to support 13 investigators at prestigious colleges and universities across the United States.
What are some of the critical determinants of a healthy and independent lifestyle for older adults?
In the largest genome-wide association study of glaucoma to date, an international team of researchers compared the genes of 34,179 people with the disease to 349,321 control subjects. They identified 127 genes linked to glaucoma, including 44 new gene loci and confirmed 83 previously reported loci.
Four brief, illuminating talks by experts on gene therapy, optic nerve regeneration, the role of artificial intelligence, and the importance of trust between physician and patient.
Coming off a successful inaugural year, Eyecelerator this week announced its slate of virtual and in-person programming scheduled for 2021, beginning with a complimentary live stream on Wednesday, March 3, 8 to 9:30 a.m. PST: Financing in the Time of COVID.
Researchers using MRI have found significant abnormalities in the eyes of some people with severe COVID-19, according to a study published in the journal Radiology.
The American Academy of Ophthalmology is highlighting what the next decade may hold for the 11 million Americans suffering from AMD.
The finding could lead to new ways to prevent cold sores and herpes-related eye disease from reoccurring, the researchers report.
Researchers at the University of Illinois Chicago have been awarded a five-year, $10.15 million grant to develop a broad-spectrum immunomodulatory eye drop.
Patients with age-related macular degeneration (AMD) who become infected with SARS-CoV-2, the virus that causes COVID-19, are at higher risk of developing severe complications including requiring supplemental oxygen and death.
A University of Utah Health ophthalmologist is investigating how lipids known as VLC-PUFAs could be used to prevent eye disease thanks to a new way to synthesize them for research.
For his research project studying neuroprotection in glaucoma, Pete Williams, PhD from the Karolinska Institutet in Stockholm was awarded the 2021 Shaffer Prize for Innovative Glaucoma Research.
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation. In data released in preprint, two AAVCOVID vaccine candidates led to robust neutralizing antibody responses in mouse and nonhuman primate models from only a single dose. The candidates were also shown to be safe and well-tolerated in both models.
Scientists at the National Eye Institute (NEI) have developed a promising gene therapy strategy for a rare disease that causes severe vision loss in childhood. A form of Leber congenital amaurosis, the disease is caused by autosomal-dominant mutations in the CRX gene, which are challenging to treat with gene therapy.
New research demonstrates that hypnosis—the process of focusing a person’s attention on a specific task or sensation—can turn a normally difficult visual task into a far easier one by helping individuals mentally “fill in the gaps” of missing visual cues.
Less than twenty years ago, most people diagnosed with advanced age-related macular degeneration (AMD) were destined to become legally blind. Today, advances in the diagnosis and treatment of AMD made possible by retina specialists allow many patients with advanced AMD to keep reading, driving and enjoying their independence.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Pfizer Ophthalmics Carl Camras Translational Research Award. The award, funded by Pfizer Ophthalmics through the ARVO Foundation, honors Dr. Carl Camras, who is highly respected for his work as a glaucoma specialist and a research scientist, by annually awarding up to three $12,000 awards to young investigators working in areas of translational research. The 2021 awardee is Alex Huang, MD, PhD of the Doheny Eye Institute and University of California in Los Angeles.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Mallinckrodt Uveitis Research Fellowship, generously funded by Mallinckrodt Pharmaceuticals. The award, funded through the ARVO Foundation, supports an early career investigator with a one-year grant of $45,000 to study an aspect of uveitis or other inflammatory conditions of the eye. The 2021 awardee is Shilpa Kodati, MD of the National Eye Institute (NEI) at the National Institutes of Health (NIH).
Dr. Mary Beth Cunnane, a radiologist who specializes in the imaging of patients with diseases of the eyes, ears, nose and head and neck, has been appointed Chief of Radiology at Mass Eye and Ear in Boston.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the 2021 recipients of the Dr. David L. Epstein Award. Jamie Craig, MBBS, FRANZCO, DPhil and Owen Siggs, MD, DPhil, are the recipients of the $100,000 award which is funded through the ARVO Foundation.
The latest episode of “On Tech and Vision with Dr. Cal Roberts” centers on the place where big ideas are born – the human brain. The host, Calvin W. Roberts, MD, President and CEO of Lighthouse Guild, explores theories of brain plasticity, sensory substitution, and sensory augmentation with his guests Dr. Patricia Grant, Director of Clinical Research at Wicab Inc., and Dr. John-Ross Rizzo, Director of Innovation and Technology and Assistant Professor in the Department of Rehabilitation Medicine and the Department of Neurology, NYU Langone Medical Center.
The Catalyst Award will be presented to Ramin Valian of Allergan, an AbbVie Company, in recognition of Allergan's ongoing leadership and commitment to the development of innovative treatments to advance glaucoma care.
Retinal cells derived from a cadaver human eye survived when transplanted into the eyes of primate models, an important advance in the development of cell therapy to treat blindness, according to a study published on January 14 in Stem Cell Reports.
In experiments in mouse tissues and human cells, Johns Hopkins Medicine researchers say they have found that removing a membrane that lines the back of the eye may improve the success rate for regrowing nerve cells damaged by blinding diseases. The findings are specifically aimed at discovering new ways to reverse vision loss caused by glaucoma and other diseases that affect the optic nerve, the information highway from the eye to the brain.
What if the degenerative eye conditions that lead to glaucoma, corneal dystrophy, and cataracts could be detected and treated before vision is impaired? Recent findings from the lab of Investigator Ting Xie, PhD, at the Stowers Institute for Medical Research point to the ciliary body as a key to unlocking this possibility.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the 2021 recipients of the Roche Collaborative Research Fellowships. Wanjiku Mathenge MBChB, MMed, MSc, PhD, Sudhir H Ranganath, PhD, and Pablo Federico Barcelona, PhD, are the recipients of the fellowships that are generously funded by F. Hoffmann-La Roche Ltd., through the ARVO Foundation.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipients of the Lewis Rudin Glaucoma Prize. The award, funded by the May and Samuel Rudin Family Foundation with support of his brother Jack Rudin via the ARVO Foundation, provides a $30,000 award in recognition of an outstanding scholarly article on glaucoma published in a peer-reviewed journal during the previous calendar year. The 2020 recipients are Iqbal Ahmad Ph.D. and Pooja Teotia, PhD, of the University of Nebraska in Omaha, Neb.
The Association for Research in Vision and Ophthalmology (ARVO) announced today the recipients of the 2021 Genentech Age-Related Macular Degeneration (AMD) Research Fellowships. The two recipients will each receive $40,000 to support research focused on an aspect of AMD. The 2021 recipients are Yi-Rong Peng, PhD and Kevin J. McHugh, PhD.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right